The conference starts in:

Early-bird deadline in:

Use FRUCT discount code at booking.com

You are here

Catching up with ONCOSMART: Rolling out an innovative solution for better personalised cancer treatment

In our special feature on blood cancer in issue 65 of Research*eu magazine, we interviewed the CEO of Italian SME Cellply, Dr Massimo Bocchi. He gave us a deeper insight into the company’s novel ex vivo diagnostic system that would be the first ever fully-automated diagnostic system to evaluate the response of fresh tumour specimens to anticancer drugs in a clinical setting. More than a year later, we catch up with him to see how much further along the road to full commercialisation they’ve travelled.